A novel resveratrol derivative induces mitotic arrest, centrosome fragmentation and cancer cell death by inhibiting γ-tubulin

[1]  K. Voralu,et al.  Expression of γ-tubulin in non-small cell lung cancer and effect on patient survival. , 2019, Histology and histopathology.

[2]  Ke Chen,et al.  Resveratrol and cancer treatment: updates , 2017, Annals of the New York Academy of Sciences.

[3]  W. S. Teo,et al.  An Emerging Role for Tubulin Isotypes in Modulating Cancer Biology and Chemotherapy Resistance , 2017, International journal of molecular sciences.

[4]  R. Cozzi,et al.  The resveratrol analogue trimethoxystilbene inhibits cancer cell growth by inducing multipolar cell mitosis , 2017, Molecular carcinogenesis.

[5]  A. Eastman,et al.  Microtubule destabilising agents: far more than just antimitotic anticancer drugs , 2017, British journal of clinical pharmacology.

[6]  P. Meraldi,et al.  The Elephant in the Room: The Role of Microtubules in Cancer. , 2017, Advances in experimental medicine and biology.

[7]  A. Plückthun,et al.  Destabilizing an interacting motif strengthens the association of a designed ankyrin repeat protein with tubulin , 2016, Scientific Reports.

[8]  M. Steinmetz,et al.  Control of microtubule organization and dynamics: two ends in the limelight , 2015, Nature Reviews Molecular Cell Biology.

[9]  Berati Cerikan,et al.  The γ-tubulin-specific inhibitor gatastatin reveals temporal requirements of microtubule nucleation during the cell cycle , 2015, Nature Communications.

[10]  H. Stark,et al.  Structural modification of resveratrol leads to increased anti-tumor activity, but causes profound changes in the mode of action. , 2015, Toxicology and applied pharmacology.

[11]  N. Ahmad,et al.  Resveratrol and cancer: Challenges for clinical translation. , 2015, Biochimica et biophysica acta.

[12]  R. Osan,et al.  Rampant centrosome amplification underlies more aggressive disease course of triple negative breast cancers , 2015, Oncotarget.

[13]  D. Pellman,et al.  Causes and consequences of centrosome abnormalities in cancer , 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.

[14]  H. Maiato,et al.  Mitotic spindle multipolarity without centrosome amplification , 2014, Nature Cell Biology.

[15]  K. Polyak,et al.  Oncogene-like induction of cellular invasion from centrosome amplification , 2014, Nature.

[16]  F. Caruso,et al.  Scavenging of hydroxyl radical by resveratrol and related natural stilbenes after hydrogen peroxide attack on DNA. , 2013, Chemico-biological interactions.

[17]  K. Brown,et al.  Resveratrol in the management of human cancer: how strong is the clinical evidence? , 2013, Annals of the New York Academy of Sciences.

[18]  Jonathan Y. Mane,et al.  Discovery of Small Molecule Inhibitors that Interact with γ‐Tubulin , 2012, Chemical biology & drug design.

[19]  D. Agard,et al.  Microtubule nucleation by γ-tubulin complexes , 2011, Nature Reviews Molecular Cell Biology.

[20]  L. Galluzzi,et al.  Mitotic catastrophe: a mechanism for avoiding genomic instability , 2011, Nature Reviews Molecular Cell Biology.

[21]  D. Spandidos,et al.  Anticancer effects of the metabolic products of the resveratrol analogue, DMU-212: structural requirements for potency. , 2011, European journal of medicinal chemistry.

[22]  Sanghee Kim,et al.  Sulfonamide derivatives of styrylheterocycles as a potent inhibitor of COX-2-mediated prostaglandin E2 production. , 2010, Bioorganic & medicinal chemistry letters.

[23]  Simone Fulda,et al.  Resveratrol and derivatives for the prevention and treatment of cancer. , 2010, Drug discovery today.

[24]  A. Rescifina,et al.  Structural determinants of resveratrol for cell proliferation inhibition potency: experimental and docking studies of new analogs. , 2010, European journal of medicinal chemistry.

[25]  A. Giordano,et al.  Differential expression and cellular distribution of γ‐tubulin and βIII‐tubulin in medulloblastomas and human medulloblastoma cell lines , 2010, Journal of cellular physiology.

[26]  Eduarda Dráberová,et al.  Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. II. γ‐tubulin , 2009, Journal of cellular physiology.

[27]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[28]  D. Compton,et al.  Deviant Kinetochore Microtubule Dynamics Underlie Chromosomal Instability , 2009, Current Biology.

[29]  William T. Silkworth,et al.  Multipolar Spindle Pole Coalescence Is a Major Source of Kinetochore Mis-Attachment and Chromosome Mis-Segregation in Cancer Cells , 2009, PloS one.

[30]  David Pellman,et al.  A Mechanism Linking Extra Centrosomes to Chromosomal Instability , 2009, Nature.

[31]  F. Bonadies,et al.  Lithium hydroxide as base in the Wittig reaction. A simple method for olefin synthesis , 2008 .

[32]  D. Agard,et al.  The lattice as allosteric effector: Structural studies of αβ- and γ-tubulin clarify the role of GTP in microtubule assembly , 2008, Proceedings of the National Academy of Sciences.

[33]  P. Baas,et al.  Class III β-Tubulin and γ-Tubulin are Co-expressed and Form Complexes in Human Glioblastoma Cells , 2007, Neurochemical Research.

[34]  Bo Zhou,et al.  Structure-activity relationship studies of resveratrol and its analogues by the reaction kinetics of low density lipoprotein peroxidation. , 2006, Bioorganic chemistry.

[35]  R. Ghidoni,et al.  Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. , 2005, The Journal of nutritional biochemistry.

[36]  Patrick A. Curmi,et al.  Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain , 2004, Nature.

[37]  R. Brouillard,et al.  Resveratrol analog (Z)‐3,5,4′‐trimethoxystilbene is a potent anti‐mitotic drug inhibiting tubulin polymerization , 2003, International journal of cancer.

[38]  R. Baruchello,et al.  Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents. , 2003, Journal of medicinal chemistry.

[39]  Timothy J. Mitchison,et al.  Probing Spindle Assembly Mechanisms with Monastrol, a Small Molecule Inhibitor of the Mitotic Kinesin, Eg5 , 2000, The Journal of cell biology.

[40]  M. Kirschner,et al.  γ-Tubulin is a highly conserved component of the centrosome , 1991, Cell.